Search research articles
Contact Us
Filters
Showing results (61-70 of 121) with videos related to
Page
of 13
Sort By:
British Journal of Cancer
|
November 7, 2014
Comparing comparators: a look at control arms in kidney cancer studies over the years
S Bracarda, C Porta, M Sisani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors
C N Sternberg, P H de Mulder, A T van Oosterom, et al.
ESMO Open
|
June 17, 2022
Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
B Tombal, C N Sternberg, M Hussain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 1, 1995
Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer
G Arcangeli, A Micheli, L Verna, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG)
V Pansadoro, P Emiliozzi, F depaula, et al.
Cancer Treatment Reports
|
June 1, 1987
Phase II trial of idarubicin in patients with pancreatic cancer
A Mittelman, G B Magill, V Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder
C N Sternberg, V Pansadoro, F Calabro, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1989
Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program
C N Sternberg, A Yagoda, H Scher, et al.
Urologic Oncology
|
January 13, 2011
Neoadjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) chemotherapy and bladder preservation for muscle-infiltrating transitional cell carcinoma of the bladder
C N Sternberg, V Pansadoro, S Lauretti, et al.
Cancer
|
September 15, 1993
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder
C N Sternberg, M G Arena, F Calabresi, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 121) with videos related to
Sort By:
Page
of 13
British Journal of Cancer
|
November 7, 2014
Comparing comparators: a look at control arms in kidney cancer studies over the years
S Bracarda, C Porta, M Sisani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors
C N Sternberg, P H de Mulder, A T van Oosterom, et al.
ESMO Open
|
June 17, 2022
Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
B Tombal, C N Sternberg, M Hussain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 1, 1995
Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer
G Arcangeli, A Micheli, L Verna, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG)
V Pansadoro, P Emiliozzi, F depaula, et al.
Cancer Treatment Reports
|
June 1, 1987
Phase II trial of idarubicin in patients with pancreatic cancer
A Mittelman, G B Magill, V Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder
C N Sternberg, V Pansadoro, F Calabro, et al.
European Journal of Cancer & Clinical Oncology
|
April 1, 1989
Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program
C N Sternberg, A Yagoda, H Scher, et al.
Urologic Oncology
|
January 13, 2011
Neoadjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) chemotherapy and bladder preservation for muscle-infiltrating transitional cell carcinoma of the bladder
C N Sternberg, V Pansadoro, S Lauretti, et al.
Cancer
|
September 15, 1993
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder
C N Sternberg, M G Arena, F Calabresi, et al.
Page
of 13